PharmaPoint:Type 2 Diabetes Global Drug Forecast and Market Analysis to 2022

Topics: Diabetes mellitus, Clinical trial, Metformin Pages: 7 (1008 words) Published: April 16, 2014
PharmaPoint: Type 2 Diabetes Global Drug Forecast and Market Analysis to 2022 On 01st JAN.2014
The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, more than doubling over this period. The main drivers of growth will be the dramatic increase in disease prevalence and physicians efforts to delay disease progression and reduce the costly burden of diabetic complications through the use of combination therapies and novel branded drugs. In the emerging markets in particular, uptake of branded drugs will increase due to rapid economic growth. We anticipate that the type 2 diabetes market will not experience a fundamental shift in the classes of drugs that are preferred by physicians. Rapid uptake of drugs from the novel class of SGLT-2 inhibitors will occur; however, DPP-4 inhibitors and GLP-1 receptor agonists will continue dominating the noninsulin type 2 diabetes space. GLP-1 receptor agonists will experience the fastest growth of all classes (CAGR of 17%), due to their weight-loss effects and their novel once-weekly administration, which is preferable to the standard once- or twice-daily therapies.  Buy this report OR know more: Scope

Overview of T2D, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines. Annualized T2D therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2012 and forecast for ten years to 2022. Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the T2D therapeutics market. Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, and detailed analysis of late-stage pipeline drugs. Analysis of the current and future market competition in the global T2D therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Market Model Features
An interactive excel forecast model based on primary research interviews and surveys with KOLs and high-prescribing physicians is included in this report*. This patient based model provides diagnosis rates, patient segmentation, treatment rates, annual costs of therapy , and indication-specific drug sales for the 10 year forecast period. The forecast model is robust, fully transparent, and easy to navigate. Moreover, our models support data presented in the reports and the complete methodology is outlined in the report and the model.

 1.1 List of Tables
 1.2 List of Figures
 2 Introduction
 2.1 Catalyst
 2.2 Related Reports
 3 Disease Overview
 3.1 Etiology and Pathophysiology
 3.1.1 Etiology
 3.1.2 Pathophysiology
 3.1.3 Prognosis
 3.1.4 Quality of Life
 3.2 Symptoms
 4 Epidemiology
 4.1 Risk Factors and Comorbidities
 4.1.1 Family history of diabetes is a strong predictor of type 2 diabetes  4.1.2 The risk of type 2 diabetes increases dramatically around age 50  4.1.3 The risk of developing type 2 diabetes increases as BMI increases  4.1.4 Gestational diabetes increases the risk of developing type 2 diabetes later in life up to 10 times  4.1.5 Up to 75% of adults with type 2 diabetes have hypertension  4.1.6 Nearly all type 2 diabetics also have dyslipidemia

 4.2 Global Trends
 4.2.1 US
 4.2.2 5EU
 4.2.3 Japan
 4.2.4 Brazil
 4.2.5 China and India
 4.3 Forecast Methodology
 4.3.1 Sources Used
 4.3.2 Forecast Assumptions and Methods
 4.3.3 Sources Not Used
 4.4 Epidemiology Forecast of Type 2 Diabetes (20122022)
 4.4.1 Prevalent Cases of Diagnosed Type 2 Diabetes
Continue Reading

Please join StudyMode to read the full document

You May Also Find These Documents Helpful

  • PharmaPoint: Ulcerative Colitis
  • PharmaPoint: Prophylactic Hepatitis B Virus Vaccines
  • Essay about Servo Motors and Drives Market
  • JSB Market Research: PharmaPoint: Dry Eye Syndrome
  • diabetes Essay
  • Global Intranasal Drug Delivery Market Essay
  • Flutiform Asthma –Drug Forecast and Market Analysis to 2023 Essay
  • Global Geocells Market Competitive Landscape Forecast 2015 to 2025 Essay

Become a StudyMode Member

Sign Up - It's Free